A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects

NCT06700083 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: SHR-6934 injection
DRUG: SHR-6934 placebo

Sponsor

Beijing Suncadia Pharmaceuticals Co., Ltd